Biolosion Combined Standard Neoadjuvant Therapy to Treat Triple-negative Breast Cancer

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2025
To evaluate the efficacy and safety of compound preparation Biolosion in combination with standard neoadjuvant therapy for locally advanced triple-negative breast cancer
Epistemonikos ID: b23bc96cf4e832758f2bbc4b00e675f6b06210d8
First added on: Feb 01, 2025